Tomoko Yamazaki

Hidaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Preventive Effects of Non-sedating and Sedating Histamine H1 Receptor Antagonists Premedication for Subcutaneous Daratumumab-Associated Infusion-Related Reactions: A Prospective Observational Study.

Preventive Effects of Non-sedating and Sedating Histamine H1 Receptor Antagonists Premedication for Subcutaneous Daratumumab-Associated Infusion-Related Reactions: A Prospective Observational Study.

Journal: Biological & pharmaceutical bulletin

Published: July 30, 2026

Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 26, 2026

An Unusual Pattern of Burns Space Metastasis From Oral Squamous Cell Carcinoma Treated by Surgical Resection: A Case Report.

An Unusual Pattern of Burns Space Metastasis From Oral Squamous Cell Carcinoma Treated by Surgical Resection: A Case Report.

Journal: Case reports in otolaryngology

Published: December 22, 2025

Molecular and Cell Biological Characterization of Patient-Derived Head and Neck Squamous Carcinoma Cell Lines.

Molecular and Cell Biological Characterization of Patient-Derived Head and Neck Squamous Carcinoma Cell Lines.

Journal: Cancer science

Published: December 04, 2025

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

Journal: Japanese journal of clinical oncology

Published: October 11, 2025

Muscle Coverage With Fibula Flaps Using Fibrin Glue and a Polyglycolic Acid Sheet: A Six-Patient Case Series.

Muscle Coverage With Fibula Flaps Using Fibrin Glue and a Polyglycolic Acid Sheet: A Six-Patient Case Series.

Journal: The Journal of craniofacial surgery

Published: September 08, 2025

Extraskeletal Larynx Osteosarcoma: Difficult Diagnosis and Early Resection.

Extraskeletal Larynx Osteosarcoma: Difficult Diagnosis and Early Resection.

Journal: Radiology. Imaging cancer

Published: July 11, 2025

Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer.

Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer.

Journal: Japanese journal of clinical oncology

Published: April 27, 2025

Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': [ESMO Open volume 9 issue 6 (2024) 103476].

Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': [ESMO Open volume 9 issue 6 (2024) 103476].

Journal: ESMO open

Published: July 21, 2024

First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.

First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.

Journal: International journal of clinical oncology

Published: June 27, 2024

Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma.

Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma.

Journal: Anticancer research

Published: June 14, 2024

Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study.

Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study.

Journal: The oncologist

Published: May 13, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026